245
Participants
Start Date
August 31, 2008
Primary Completion Date
January 31, 2009
Study Completion Date
February 28, 2009
Bupivacaine HCl
200 mg bupivacaine HCl
SKY0402
600 mg SKY0402 (study drug).
Insall Scott Kelly Institute, New York
Ilumina Clinical Associates, Johnstown
Allegheny Pain Management, Altoona
Duke University Medical Center, Raleigh-Durham
CTMG, Inc., Greenville
Atlanta Knee and Sports Medicine, Decatur
West Alabama Research, Inc., Birmingham
Drug Research and Analysis Corporation, Montgomery
Horizon Research Group, Inc., Alabama Orthopaedic Clinic, Mobile
Research Associates of Jackson, Jackson
Ohio State University Medical Center, Columbus
Rush University Medical Center, Chicago
Texas Orthopedic Specialists, PA, Grapevine
Memorial Hermann City Hospital, Houston
Sun Health Research Institute, Core Institute, Sun City West
Cedars of Sinai Medical Center, Los Angeles
Scripps, La Jolla
Accurate Clinical Trials, Inc., Laguna Hills
Physicans Clinical Research Corp., Laguna Hills
Lead Sponsor
Pacira Pharmaceuticals, Inc
INDUSTRY